Drug Trial Radar · NCT06419608
Efficacy and Safety Study of BHV-7000 Monotherapy in Major Depression
Last checked: Nov 20, 2026Latest source record: Oct 14, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
336
Actual
Start
May 28, 2024
Primary completion
Nov 7, 2025
Study completion Nov 7, 2025
Sponsor
- Lead sponsor
- Biohaven Therapeutics Ltd.Industry
- Sponsor type
- Industry
- First posted
- May 17, 2024
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to determine the efficacy and safety of BHV-7000 in participants with Major Depressive Disorder (MDD)
Conditions
- Major Depressive Disorder
Interventions
BHV-7000Drug
BHV-7000 75 mg taken once daily for 6 weeks
PlaceboDrug
Matching placebo taken once daily for 6 weeks
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in Montgomery- Åsberg Depression Rating Scale (MADRS) total score from baseline to week 6Time frame: Baseline to Week 6
Locations
62 sites in 1 country. Site status is shown where the registry gives one.
IMA Clinical Research
Phoenix, Arizona
Pillar Clinical Research, LLC
Little Rock, Arkansas
WIRG
Little Rock, Arkansas
WRN
Rogers, Arkansas
Advanced Research Center, Inc.
Anaheim, California
CIT LA
Bellflower, California
IPMG
Chino, California
WR-PRI Encino
Encino, California
Collaborative Neuroscience Research, LLC (CenExel - CNS)
Garden Grove, California
CalNeuro Research Group
Los Angeles, California
Excell Research, Inc.
Oceanside, California
NRC Research Institute
Orange, California
Anderson Clinical Research
Redlands, California
CIT IE
Riverside, California
Lumos Clinical Research Center
San Jose, California
Stanford
Stanford, California
Cenexel CNS
Torrance, California
Pacific Clinical Research Management Group
Upland, California
Sunwise Clinical Research
Walnut Creek, California
MCB Clinical Research Centers
Colorado Springs, Colorado
UConn Health
Farmington, Connecticut
Optum Behavioral Care of Connecticut, PC dba Comprehensive Psychiatric Care of Connecticut
Norwich, Connecticut
Clinical Neuroscience Solutions, Inc
Jacksonville, Florida
Floridian Neuroscience Institute
Miami Lakes, Florida
Clinical Neuroscience Solutions, Inc.
Orlando, Florida
K2 Medical Research
Tampa, Florida
Neuroscience Research Institute
West Palm Beach, Florida
CenExel iResearch, LLC
Decatur, Georgia
CenExel iResearch, LLC
Savannah, Georgia
Uptown Research Institute
Chicago, Illinois
Revive Research Institute, Inc.
Elgin, Illinois
Collective Medical Research
Overland Park, Kansas
Delricht Research
New Orleans, Louisiana
Headlands Pharmasite
Baltimore, Maryland
CBH Health
Gaithersburg, Maryland
Copley Clinical
Boston, Massachusetts
Boston Clinical Trials
Boston, Massachusetts
Adams Clinical
Watertown, Massachusetts
Precise Clinical Research
Flowood, Mississippi
Arch Clinical Trials
St Louis, Missouri
Showing 40 of 62 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.